Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Antoni Ribas(University of California, Los Angeles), Igor Puzanov(Vanderbilt University), Reinhard Dummer(University of Zurich), Dirk Schadendorf(Essen University Hospital), Omid Hamid(Angeles Clinic and Research Institute), Caroline Robert(Université Paris-Sud), F. Stephen Hodi(Dana-Farber Cancer Institute), Jacob Schachter(Sheba Medical Center), Anna C. Pavlick(New York University), Karl D. Lewis(University of Colorado Denver), Lee D. Cranmer(University of Arizona), Christian U. Blank(Dutch Cancer Society), Steven O’Day(Beverly Hills Cancer Center), Paolo A. Ascierto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), April K.S. Salama(Duke Cancer Institute), Kim Margolin(Seattle Cancer Care Alliance), Carmen Loquai(Johannes Gutenberg University Mainz), Thomas Eigentler(Universitätsklinikum Tübingen), Tara C. Gangadhar(University of Pennsylvania), Matteo S. Carlino(Blacktown & Mount Druitt Hospital), Sanjiv S. Agarwala(St. Luke's University Health Network), Stergios J. Moschos(University of North Carolina at Chapel Hill), Jeffrey A. Sosman(Vanderbilt University), Simone M. Goldinger(University of Zurich), Ronnie Shapira‐Frommer(Sheba Medical Center), René González(University of Colorado Denver), John M. Kirkwood(University of Pittsburgh), Jedd D. Wolchok(Memorial Sloan Kettering Cancer Center), Alexander M.M. Eggermont(Université Paris-Sud), Xiaoyun Li(Merck & Co., Inc., Rahway, NJ, USA (United States)), Wei Zhou(Merck & Co., Inc., Rahway, NJ, USA (United States)), Adriane M Zernhelt(Merck & Co., Inc., Rahway, NJ, USA (United States)), Joy Lis(Merck & Co., Inc., Rahway, NJ, USA (United States)), Scot Ebbinghaus(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sunyu Kang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Adil Daud(University of California, San Francisco)
Cited by 1,561Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis